UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differential expression of inflammasomes in lung cancer cell lines and tissues

Tumor biology, 2015-09, Vol.36 (10), p.7501-7513

2015

Volltextzugriff (PDF)

Evaluating Oral Probiotic Supplements as Complementary Treatment in Advanced Lung Cancer Patients Receiving ICIs: A Prospective Real-World Study

Cancer control, 2024-01, Vol.31, p.10732748241253959-10732748241253959

2024

Volltextzugriff (PDF)

The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy

Integrative cancer therapies, 2015-07, Vol.14 (4), p.341-349

2015

Volltextzugriff (PDF)

Clinical Evaluation and Therapeutic Monitoring Value of Serum Tumor Markers in Lung Cancer

The International journal of biological markers, 2016-01, Vol.31 (1), p.80-87

2016

Volltextzugriff (PDF)

Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma

Tumor biology, 2016, Vol.37 (1), p.1173-1182

2016

Volltextzugriff (PDF)

Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer

Tumor biology, 2016-02, Vol.37 (2), p.2193-2207

2016

Volltextzugriff (PDF)

Usefulness of Serum Tumor Markers, Including Progastrin-Releasing Peptide, in Patients with Lung Cancer: Correlation with Histology

Tumor biology, 2009-01, Vol.30 (3), p.121-129

2009

Volltextzugriff (PDF)

Triple synchronous primary lung cancer

Asian cardiovascular & thoracic annals, 2014-09, Vol.22 (7), p.865-868

2014

Volltextzugriff (PDF)

LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis

International journal of immunopathology and pharmacology, 2019, Vol.33, p.2058738419859699-2058738419859699

2019

Volltextzugriff (PDF)

CYFRA21-1 tests in the diagnosis of non-small cell lung cancer: A meta-analysis

The International journal of biological markers, 2019-09, Vol.34 (3), p.251-261

2019

Volltextzugriff (PDF)

The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients

Tumor biology, 2015-05, Vol.36 (5), p.3389-3397

2015

Volltextzugriff (PDF)

SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer

Tumor biology, 2014-11, Vol.35 (11), p.10699-10705

2014

Volltextzugriff (PDF)

MiR-222-3p Promotes Cell Proliferation and Inhibits Apoptosis by Targeting PUMA (BBC3) in Non-Small Cell Lung Cancer

Technology in cancer research & treatment, 2020, Vol.19, p.1533033820922558-1533033820922558

2020

Volltextzugriff (PDF)

Efficacy of rapid on-site cytological evaluation (ROSE) by a pulmonologist in determining specimen adequacy and diagnostic accuracy in interventional diagnosis of lung lesions

Journal of international medical research, 2021-02, Vol.49 (2), p.300060520982687-300060520982687

2021

Volltextzugriff (PDF)

Clinical Significance of Kinetics of Low-Density Lipoprotein Cholesterol and Its Prognostic Value in Limited Stage Small Cell Lung Cancer Patients

Cancer control, 2021-01, Vol.28, p.10732748211028257-10732748211028257

2021

Volltextzugriff (PDF)

Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis

Cancer control, 2021, Vol.28, p.10732748211050581-10732748211050581

2021

Volltextzugriff (PDF)

Risk factors and nomograms for diagnosis and early death in patients with combined small cell lung cancer with distant metastasis: a population-based study

Journal of international medical research, 2024-09, Vol.52 (9), p.3000605241238689

2024

Volltextzugriff (PDF)

Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer

Experimental biology and medicine (Maywood, N.J.), 2020-10, Vol.245 (16), p.1428-1436

2020

Volltextzugriff (PDF)

High Biologically Effective Dose Radiotherapy for Brain Metastases May Improve Survival and Decrease Risk for Local Relapse Among Patients With Small-Cell Lung Cancer: A Propensity-Matching Analysis

Cancer control, 2020-04, Vol.27 (2), p.1073274820936287

2020

Volltextzugriff (PDF)

Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study

Cancer control, 2021, Vol.28, p.10732748211051228-10732748211051228

2021

Volltextzugriff (PDF)

The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis

Tumori, 2023-04, Vol.109 (2), p.203-214

2023

Volltextzugriff (PDF)

Contribution of F-18 fluorodeoxyglucose PET/CT and contrast-enhanced thoracic CT texture analyses to the differentiation of benign and malignant mediastinal lymph nodes

Acta radiologica (1987), 2023-04, Vol.64 (4), p.1443-1454

2023

Volltextzugriff (PDF)

Autoimmune encephalitis following treatment with durvalumab for small-cell lung cancer

Journal of international medical research, 2024-10, Vol.52 (10), p.3000605241287015

2024

Volltextzugriff (PDF)

Roles of Lipid Profiles in Human Non-Small Cell Lung Cancer

Technology in Cancer Research & Treatment, 2021-01, Vol.20, p.15330338211041472-15330338211041472

2021

Volltextzugriff (PDF)

Predictability of Neutrophile to Lymphocyte Ratio and Platelet to Lymphocyte Ratio on the Effectiveness of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer patients: A Meta-Analysis

Cancer control, 2024-09, Vol.31, p.10732748241285474

2024

Volltextzugriff (PDF)

1 – 25 von 971

Suche als RSS-Feed

Aktive Filter

KollektionSage Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(915)
Mit Volltextzugriff
(907)

Publikationsform

Artikel
(970)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(952)
Science & Technology
(824)
Life Sciences & Biomedicine
(821)
Lung Neoplasms - Pathology
(742)
Carcinoma, Non-Small-Cell Lung - Pathology
(646)
Oncology
(595)
Male
(588)
Female
(577)
Lung Cancer
(526)
Middle Aged
(526)
Aged
(483)
Adult
(304)
Neoplasm Staging
(287)
Carcinoma, Non-Small-Cell Lung - Genetics
(282)
Prognosis
(264)
Cancer Research
(254)
Biomedicine
(251)
Biomedical And Life Sciences
(241)
Lung Neoplasms - Genetics
(214)
Non-Small Cell Lung Cancer
(214)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

10 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Differential expression of inflammasomes in lung cancer cell lines and tissues

Evaluating Oral Probiotic Supplements as Complementary Treatment in Advanced Lung Cancer Patients Receiving ICIs: A Prospective Real-World Study

The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy

Clinical Evaluation and Therapeutic Monitoring Value of Serum Tumor Markers in Lung Cancer

Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma

Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer

Usefulness of Serum Tumor Markers, Including Progastrin-Releasing Peptide, in Patients with Lung Cancer: Correlation with Histology

Triple synchronous primary lung cancer

LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis

CYFRA21-1 tests in the diagnosis of non-small cell lung cancer: A meta-analysis

The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients

SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer

MiR-222-3p Promotes Cell Proliferation and Inhibits Apoptosis by Targeting PUMA (BBC3) in Non-Small Cell Lung Cancer

Efficacy of rapid on-site cytological evaluation (ROSE) by a pulmonologist in determining specimen adequacy and diagnostic accuracy in interventional diagnosis of lung lesions

Clinical Significance of Kinetics of Low-Density Lipoprotein Cholesterol and Its Prognostic Value in Limited Stage Small Cell Lung Cancer Patients

Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis

Risk factors and nomograms for diagnosis and early death in patients with combined small cell lung cancer with distant metastasis: a population-based study

Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer

High Biologically Effective Dose Radiotherapy for Brain Metastases May Improve Survival and Decrease Risk for Local Relapse Among Patients With Small-Cell Lung Cancer: A Propensity-Matching Analysis

Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study

The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis

Contribution of F-18 fluorodeoxyglucose PET/CT and contrast-enhanced thoracic CT texture analyses to the differentiation of benign and malignant mediastinal lymph nodes

Autoimmune encephalitis following treatment with durvalumab for small-cell lung cancer

Roles of Lipid Profiles in Human Non-Small Cell Lung Cancer

Predictability of Neutrophile to Lymphocyte Ratio and Platelet to Lymphocyte Ratio on the Effectiveness of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer patients: A Meta-Analysis

Aktive Filter

Suchergebnisse filtern